MEOBF
Price
$0.96
Change
-$0.00 (-0.00%)
Updated
Jun 23 closing price
Capitalization
1.4B
55 days until earnings call
MLLCF
Price
$4.22
Change
-$0.00 (-0.00%)
Updated
Apr 25 closing price
Capitalization
141.37M
Interact to see
Advertisement

MEOBF vs MLLCF

Header iconMEOBF vs MLLCF Comparison
Open Charts MEOBF vs MLLCFBanner chart's image
Mesoblast
Price$0.96
Change-$0.00 (-0.00%)
Volume$1K
Capitalization1.4B
Molecular Partners AG
Price$4.22
Change-$0.00 (-0.00%)
Volume$1.33K
Capitalization141.37M
MEOBF vs MLLCF Comparison Chart in %
Loading...
MEOBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MEOBF vs. MLLCF commentary
Jul 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MEOBF is a Buy and MLLCF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 03, 2025
Stock price -- (MEOBF: $0.96 vs. MLLCF: $4.22)
Brand notoriety: MEOBF and MLLCF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MEOBF: 79% vs. MLLCF: 100%
Market capitalization -- MEOBF: $1.4B vs. MLLCF: $141.37M
MEOBF [@Biotechnology] is valued at $1.4B. MLLCF’s [@Biotechnology] market capitalization is $141.37M. The market cap for tickers in the [@Biotechnology] industry ranges from $307.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MEOBF’s FA Score shows that 0 FA rating(s) are green whileMLLCF’s FA Score has 0 green FA rating(s).

  • MEOBF’s FA Score: 0 green, 5 red.
  • MLLCF’s FA Score: 0 green, 5 red.
According to our system of comparison, MLLCF is a better buy in the long-term than MEOBF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MEOBF’s TA Score shows that 4 TA indicator(s) are bullish.

  • MEOBF’s TA Score: 4 bullish, 3 bearish.

Price Growth

MEOBF (@Biotechnology) experienced а 0.00% price change this week, while MLLCF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.20%. For the same industry, the average monthly price growth was +33.12%, and the average quarterly price growth was +1.51%.

Reported Earning Dates

MEOBF is expected to report earnings on Aug 27, 2025.

Industries' Descriptions

@Biotechnology (+1.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MEOBF($1.4B) has a higher market cap than MLLCF($141M). MLLCF YTD gains are higher at: 2.676 vs. MEOBF (-56.136). MLLCF has higher annual earnings (EBITDA): -57.15M vs. MEOBF (-77.78M). MLLCF has more cash in the bank: 131M vs. MEOBF (37.7M). MLLCF has less debt than MEOBF: MLLCF (2.14M) vs MEOBF (126M). MEOBF has higher revenues than MLLCF: MEOBF (5.67M) vs MLLCF (2.23M).
MEOBFMLLCFMEOBF / MLLCF
Capitalization1.4B141M992%
EBITDA-77.78M-57.15M136%
Gain YTD-56.1362.676-2,097%
P/E RatioN/AN/A-
Revenue5.67M2.23M254%
Total Cash37.7M131M29%
Total Debt126M2.14M5,885%
FUNDAMENTALS RATINGS
MEOBF vs MLLCF: Fundamental Ratings
MEOBF
MLLCF
OUTLOOK RATING
1..100
3647
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
36
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9597
PRICE GROWTH RATING
1..100
6559
P/E GROWTH RATING
1..100
5987
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MLLCF's Valuation (36) in the null industry is somewhat better than the same rating for MEOBF (88). This means that MLLCF’s stock grew somewhat faster than MEOBF’s over the last 12 months.

MLLCF's Profit vs Risk Rating (100) in the null industry is in the same range as MEOBF (100). This means that MLLCF’s stock grew similarly to MEOBF’s over the last 12 months.

MEOBF's SMR Rating (95) in the null industry is in the same range as MLLCF (97). This means that MEOBF’s stock grew similarly to MLLCF’s over the last 12 months.

MLLCF's Price Growth Rating (59) in the null industry is in the same range as MEOBF (65). This means that MLLCF’s stock grew similarly to MEOBF’s over the last 12 months.

MEOBF's P/E Growth Rating (59) in the null industry is in the same range as MLLCF (87). This means that MEOBF’s stock grew similarly to MLLCF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MEOBFMLLCF
RSI
ODDS (%)
Bullish Trend 4 days ago
44%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
50%
N/A
Momentum
ODDS (%)
Bullish Trend 4 days ago
50%
N/A
MACD
ODDS (%)
Bearish Trend 4 days ago
62%
N/A
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
53%
Bullish Trend 4 days ago
49%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
52%
Bullish Trend 4 days ago
47%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
55%
N/A
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
MEOBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JOGIX11.940.12
+1.02%
JOHCM Global Select Institutional
ISTIX81.990.57
+0.70%
Macquarie Science and Technology I
MUEUX37.850.16
+0.42%
MFS Blended Research Core Equity R4
VREMX8.450.02
+0.24%
Virtus SGA Emerging Markets Equity R6
MSIBX19.67N/A
N/A
Morgan Stanley Inst Passport ovrs eq A

MEOBF and

Correlation & Price change

A.I.dvisor tells us that MEOBF and RLYB have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MEOBF and RLYB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MEOBF
1D Price
Change %
MEOBF100%
N/A
RLYB - MEOBF
25%
Poorly correlated
+1.62%
ADIL - MEOBF
24%
Poorly correlated
N/A
MMIRF - MEOBF
10%
Poorly correlated
N/A
MLLCF - MEOBF
6%
Poorly correlated
N/A
IPHYF - MEOBF
5%
Poorly correlated
N/A
More

MLLCF and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLLCF has been loosely correlated with ENSC. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if MLLCF jumps, then ENSC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLLCF
1D Price
Change %
MLLCF100%
N/A
ENSC - MLLCF
40%
Loosely correlated
-0.45%
HNSBF - MLLCF
28%
Poorly correlated
N/A
VICP - MLLCF
28%
Poorly correlated
N/A
GNPX - MLLCF
26%
Poorly correlated
+2.20%
KALA - MLLCF
23%
Poorly correlated
+3.03%
More